ENTRY       D10708                      Drug
NAME        Fostemsavir tromethamine (USAN);
            Fostemsavir trometamol;
            Rukobia (TN)
  ABBR      FTR
PRODUCT     RUKOBIA (ViiV Healthcare Company)
FORMULA     C25H26N7O8P. C4H11NO3
EXACT_MASS  704.2319
MOL_WEIGHT  704.6248
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Transporter substrate
             DG01665  ABCB1 substrate
             DG01913  ABCG2 substrate
            Transporter inhibitor
             DG02862  ABCG2 inhibitor
             DG02865  SLCO1B1 inhibitor
             DG02907  SLCO1B3 inhibitor
REMARK      ATC code: J05AX29
            Chemical structure group: DG01860
            Product (DG01860): D10708<US>
EFFICACY    Antiviral, gp120-directed attachment inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
COMMENT     Active form of prodrug: Temsavir [DR:D10734]
            Treatment of HIV
TARGET      HIV-1 gp120 [KO:K24266]
  PATHWAY   ko03230(K24266)  Viral genome structure
            ko03250(K24266)  Viral life cycle - HIV-1
            ko03260(K24266)  Virion - Human immunodeficiency virus
            ko04061(K24266)  Viral protein interaction with cytokine and cytokine receptor
            ko05170(K24266)  Human immunodeficiency virus 1 infection
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
            Transporter: ABCB1 [HSA:5243], ABCG2 [HSA:9429]
INTERACTION Transporter inhibition: ABCG2 [HSA:9429], SLCO1B1 [HSA:10599], SLCO1B3 [HSA:28234]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AX Other antivirals
                 J05AX29 Fostemsavir
                  D10708  Fostemsavir tromethamine (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Other
               Fostemsavir
                D10708  Fostemsavir tromethamine (USAN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG01860  Temsavir
                D10708  Fostemsavir tromethamine
             Transporter substrate
              DG01665  ABCB1 substrate
               DG01860  Temsavir
                D10708  Fostemsavir tromethamine
              DG01913  ABCG2 substrate
               DG01860  Temsavir
                D10708  Fostemsavir tromethamine
             Transporter inhibitor
              DG02862  ABCG2 inhibitor
               DG01860  Temsavir
                D10708  Fostemsavir tromethamine
              DG02865  SLCO1B1 inhibitor
               DG01860  Temsavir
                D10708  Fostemsavir tromethamine
              DG02907  SLCO1B3 inhibitor
               DG01860  Temsavir
                D10708  Fostemsavir tromethamine
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               HIV gp41/gp120
                D10708  Fostemsavir tromethamine (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10708
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10708
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10708
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10708
             Drug transporters
              D10708
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG01860  Temsavir
             Transporter substrate
              DG01665  ABCB1 substrate
               DG01860  Temsavir
              DG01913  ABCG2 substrate
               DG01860  Temsavir
             Transporter inhibitor
              DG02862  ABCG2 inhibitor
               DG01860  Temsavir
              DG02865  SLCO1B1 inhibitor
               DG01860  Temsavir
              DG02907  SLCO1B3 inhibitor
               DG01860  Temsavir
            Prodrugs [br08324.html(DG01860)]
             DG01860
DBLINKS     CAS: 864953-39-9
            PubChem: 254741669
ATOM        49
            1   N5x N    16.9400  -18.2700
            2   C8x C    18.1300  -18.9700
            3   C8y C    19.3900  -18.2700
            4   C8y C    19.3900  -16.8700
            5   C8y C    18.1300  -16.1700
            6   C8y C    16.9400  -16.8700
            7   C8y C    20.3700  -15.8900
            8   C8x C    19.8100  -14.6300
            9   N4y N    18.4100  -14.7700
            10  N4y N    15.7500  -16.1700
            11  C8x C    15.5400  -14.7700
            12  N5x N    14.2100  -14.4900
            13  C8y C    13.5100  -15.7500
            14  N5x N    14.4900  -16.7300
            15  C1a C    12.1100  -15.7500
            16  C1b C    17.4300  -13.7900
            17  O2b O    17.7800  -12.4600
            18  P1b P    16.8000  -11.4800
            19  O1c O    17.7800  -10.5000
            20  O1c O    15.8200  -12.4600
            21  O1c O    15.8200  -10.5000
            22  O2a O    20.5800  -18.9700
            23  C1a C    20.5800  -20.3700
            24  C5a C    21.7700  -16.2400
            25  O5a O    22.7500  -15.1900
            26  C5a C    22.4700  -17.5000
            27  O5a O    21.4900  -18.4800
            28  N1y N    23.8000  -17.8500
            29  C1x C    24.1500  -19.1800
            30  C1x C    25.5500  -19.5300
            31  N1y N    26.5300  -18.5500
            32  C1x C    26.1800  -17.2200
            33  C1x C    24.7800  -16.8000
            34  C8x C    27.2300  -21.2100
            35  C8y C    28.2800  -20.2300
            36  C5a C    27.8600  -18.9000
            37  C8x C    27.6500  -22.6100
            38  C8x C    28.9800  -22.9600
            39  C8x C    29.9600  -21.9100
            40  C8x C    29.6100  -20.5800
            41  O5a O    28.8400  -17.9200
            42  O1a O    30.1700  -15.0500
            43  C1b C    31.3600  -14.4200
            44  C1d C    32.6200  -15.0500
            45  C1b C    33.8100  -14.4200
            46  O1a O    35.0700  -15.0500
            47  N1a N    32.6200  -13.6500
            48  C1b C    32.6200  -16.4500
            49  O1a O    33.8800  -17.2200
BOND        52
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    5   9 1
            11    6  10 1
            12   10  11 1
            13   11  12 2
            14   12  13 1
            15   13  14 2
            16   10  14 1
            17   13  15 1
            18    9  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   18  20 1
            23   18  21 2
            24    3  22 1
            25   22  23 1
            26    7  24 1
            27   24  25 2
            28   24  26 1
            29   26  27 2
            30   26  28 1
            31   28  29 1
            32   29  30 1
            33   30  31 1
            34   31  32 1
            35   32  33 1
            36   28  33 1
            37   34  35 2
            38   35  36 1
            39   31  36 1
            40   34  37 1
            41   37  38 2
            42   38  39 1
            43   39  40 2
            44   35  40 1
            45   36  41 2
            46   42  43 1
            47   43  44 1
            48   44  45 1
            49   45  46 1
            50   44  47 1
            51   44  48 1
            52   48  49 1
///
